References
- 1. P. Sharma, Cinnamic acid derivatives: A new chapter of various pharmacological activities, J. Chem. Pharm. Res.3 (2011) 403–423.
- 2. J. D. Guzman, Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity, Molecules19 (2014) 292–349; https://doi.org/10.3390/molecules191219292
- 3. R. Lone, R. Shuab and K. K. Koul, Role of cinnamate and cinnamate derivatives in pharmacology, Glob. J. Pharmacol.8 (2014) 328–335; https://doi.org/10.5829/idosi.gjp.2014.8.3.83132
- 4. M. Sova, Antioxidant and antimicrobial activities of cinnamic acid derivatives, Mini Rev. Med. Chem.12 (2012) 749–767; https://doi.org/10.2174/138955712801264792
- 5. M. K. Lee, Y. B. Park, S. S. Moon, S. H. Bok, D. J. Kim, T. Y. Ha, T. S. Jeong, K. S. Jeong and M. S. Choi, Hypocholesterolemic and antioxidant properties of 3-(4-hydroxyl)propanoic acid derivatives in high-cholesterol fed rats, Chem.-Biol. Interact.170 (2007) 9–19; https://doi.org/10.1016/j.cbi.2007.06.037
- 6. J. Zhang, J. Yang, X. Chang, C. Zhang, H. Zhou and M. Liu, Ozagrel for acute ischemic stroke: a meta-analysis of data from randomized controlled trials, Neurol. Res.34 (2012) 346–353; https://doi.org/10.1179/1743132812Y.0000000022
- 7. J. Kanaani and H Ginsburg, Effects of cinnamic acid derivatives on in vitro growth of Plasmodium falciparum and on the permeability of the membrane of malaria-infected erythrocytes, Antimicrob. Agents Chemother.36 (1992) 1102–1108.
- 8. B. Pérez, C. Teixeira, A. S. Gomes, I. S. Albuquerque, J. Gut, P. J. Rosenthal, M. Prudêncio and P. Gomes, In vitro efficiency of 9-(N-cinnamoylbutyl)aminoacridines against blood- and liver-stage malaria parasites, Bioorg. Med. Chem. Lett.23 (2013) 610–613; https://doi.org/10.1016/j.bmcl.2012.12.032
- 9. B. C. Pérez, C. Teixeira, M. Figueiras, J. Gut, P. J. Rosenthal, J. R. B. Gomes and P. Gomes, Novel cinnamic acid/4-aminoquinoline conjugates bearing non-proteinogenic amino acids: Towards the development of potential dual action antimalarials, Eur. J. Med. Chem.54 (2012) 887–899; https://doi.org/10.1016/j.ejmech.2012.05.022
- 10. B. C. Pérez, I. Fernandes, N. Mateus, C. Teixeira and P. Gomes, Recycling antimalarial leads for cancer: Antiproliferative properties of N-cinnamoyl chloroquine analogues, Bioorg. Med. Chem. Lett.23 (2013) 6769–6772; https://doi.org/10.1016/j.bmcl.2013.10.025
- 11. K. Frenkel, H. Wei, R. Bhimani, J. Ye, J. A. Zadunaisky, M.-T. Huang, T. Ferraro, A. H. Conney and D. Grunberger, Inhibition of tumor promoter-mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester, Cancer Res.53 (1993) 1255–1261.
- 12. L. Liu,W. R. Hudgins, S. Shack, M. Q. Yin and D. Samid, Cinnamic acid: a natural product with potential use in cancer intervention, Int. J. Cancer62 (1995) 345–350.
- 13. S. Mishima, Y. Ono, Y. Araki, Y. Akao and Y. Nozawa, Two related cinnamic acid derivatives from Brazilian honey bee propolis, baccharin and drupanin, induce growth inhibition in allografted sarcoma S-180 in mice, Biol. Pharm. Bull.28 (2005) 1025–1030; https://doi.org/10.1248/bpb.28.1025
- 14. Y. Qian, H.-J. Zhang, H. Zhang, C. Xu, J. Zhao and H.-L. Zhu, Synthesis, molecular modeling, and biological evaluation of cinnamic acid metronidazole ester derivatives as novel anticancer agents, Bioorg. Med. Chem.18(2010) 4991–4996; https://doi.org/10.1016/j.bmc.2010.06.003
- 15. J. Dai and J. M. Russell, Plant phenolics: Extraction, analysis and their antioxidant and anticancer properties, Molecules15 (2010) 7313–7352; https://doi.org/10.3390/molecules15107313
- 16. X.-H. Yang, Q. Wen, T.-T. Zhao, J. Sun, X. Li, M. Xing, X. Lu and H.-L. Zhu, Synthesis, biological evaluation, and molecular docking studies of cinnamic acyl 1,3,4-thiadiazole amide derivatives as novel antitubulin agents, Bioorg. Med. Chem.20 (2012) 1181–1187; https://doi.org/10.1016/j.bmc.2011.12.057
- 17. D. P. Bezerra, C. Pessoa, M. O. de Moraes, N. Saker-Neto, E. R. Silveira and L. v. Costa-Lotufo, Overview of the therapeutic potential of piplartine (piperlongumine), Eur. J. Pharm. Sci.48 (2013) 453–463; https://doi.org/10.1016/j.ejps.2012.12.003
- 18. C.-C. Xu, T. Deng, M.-L. Fan, W.-B. Lv, J.-H. Liu and B.-Y. Yu, Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives, Eur. J. Med. Chem.107 (2016) 192–203; https://doi.org/10.1016/j.ejmech.2015.11.003
- 19. P. Su, Y. Shi, J. Wang, X. Shen and J. Zhang, Anticancer agents derived from natural cinnamic acids, Anticancer Agents Med Chem.15 (2015) 980–987; https://doi.org/10.2174/1871520615666150130111120
- 20. P. De, M. Baltas and F. Bedos-Belval, Cinnamic acid derivatives as anticancer agents - a review, Curr. Med. Chem.18 (2011) 1672–1703; https://doi.org/10.2174/092986711795471347
- 21. J. A. Plumb, P. W. Finn, R. J. Williams, M. J. Bandara, M. R. Romero, C. J. Watkins, N. B. La Thangue and R. Brown, Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101, Mol. Cancer Ther.2 (2003) 721–728.
- 22. P. Revill, N. Mealy, N. Serradell, J. Bolos and E. Rosa, Panobinistat, Drugs Fut.32 (2007) 315–322; https://doi.org/10.1358/dof.2007.032.04.1094476
- 23. K. Pavić, I. Perković, P. Gilja, F. Kozlina, K. Ester, M. Kralj, D. Schols, D. Hadjipavlou-Litina, E. Pontiki and B. Zorc, Design, synthesis and biological evaluation of novel primaquine-cinnamic acid conjugates of amide and acylsemicarbazide type, Molecules21 (2016) 1629–1653; https://doi.org/10.3390/molecules21121629
- 24. K. Pavić, I. Perković, Š. Pospíšilová, M. Machado, D. Fonthinha, M. Prudêncio, J. Jampilek. A. Coffey, L. Endersen, H. Rimac and B. Zorc, Primaquine hybrids as promising antimycobacterial and antimalarial agents, Eur. J. Med. Chem.143 (2018) 769–779; https://doi.org/10.1016/j.ejmech.2017.11.083
- 25. Z. Herceg and Z. Q. Wang, Functions of poly (ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death, Mutat. Res.477 (2001) 97–110; https://doi.org/10.1016/S0027-5107(01)00111-7
- 26. I. Perković, M. Antunović, I. Marijanović, K. Pavić, K. Ester, M. Kralj, J. Vlainić, I. Kosalec, D. Schols, D. Hadjipavlou-Litina, E. Pontiki and B. Zorc, Novel urea and bis-urea primaquine derivatives with hydroxyphenyl and halogenphenyl substituents: Synthesis and biological evaluation, Eur. J. Med. Chem.124 (2016) 622–636; https://doi.org/10.1016/j.ejmech.2016.08.021
- 27. S. Hector and J. H. Prehn, Apoptosis signalling proteins as prognostic biomarkers in colorectal cancer: A review, BBA-Rev. Cancer1795 (2009) 117–129; https://doi.org/10.1016/j.bbcan.2008.12.002
- 28. P. Mabeta and M. S. Pepper, Inhibition of hemangioma development in a syngeneic mouse model correlates with Bcl-2 suppression and the inhibition of Akt kinase activity, Angiogenesis15 (2012) 131–139; https://doi.org/10.1007/s10456-011-9248-7
- 29. P. Mabeta, PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation, Acta Pharm.66 (2016) 399–410; https://doi.org/10.1515/acph-2016-0031
- 30. I. Ojima, D. Awasthi, L. Wei and K. Haranahalli, Strategic incorporation of fluorine in the drug discovery of new-generation antitubercular agents targeting bacterial cell division protein FtsZ, J. Fluorine Chem.196 (2017) 44–56; https://doi.org/10.1016/j.jfluchem.2016.07.020
- 31. H.-J. Böhm, D. Banner, S. Bendels, M. Kansy, B. Kuhn, K. Müller, U. Obst-Sander and M. Stahl, Fluorine in medicinal chemistry, ChemBioChem5 (2004) 637–643; https://doi.org/10.1002/cbic.200301023